This is an old revision of this page, as edited by Beetstra (talk | contribs) at 17:59, 16 February 2012 (Saving copy of the {{chembox}} taken from revid 420675070 of page 3-Nitrobenzanthrone for the Chem/Drugbox validation project (updated: 'CASNo').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 17:59, 16 February 2012 by Beetstra (talk | contribs) (Saving copy of the {{chembox}} taken from revid 420675070 of page 3-Nitrobenzanthrone for the Chem/Drugbox validation project (updated: 'CASNo').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{chembox}}) taken from revid 420675070 of page 3-Nitrobenzanthrone with values updated to verified values. |
Names | |
---|---|
IUPAC name 3-Nitro-3,3a-dihydro-benzoanthracen-7-one | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C17H9NO3 |
Molar mass | 275.26 g/mol |
Melting point | 248 °C |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
Chemical compound
- Hansen, Tanja; Seidel, Albrecht; Borlak, Juergen (2007). "The environmental carcinogen 3-nitrobenzanthrone and its main metabolite 3-aminobenzanthrone enhance formation of reactive oxygen intermediates in human A549 lung epithelial cells". Toxicology and Applied Pharmacology. 221 (2): 222–234. doi:10.1016/j.taap.2007.03.003. PMID 17477947.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)